References
- MajidSSalihMWasayaRJafriWPredictors of gastrointestinal lesions on endoscopy in iron deficiency anemia without gastrointestinal symptomsBMC Gastroenterol200885218992171
- NivEElisAZissinRNaftaliTNovisBLishnerMIron deficiency anemia in patients without gastrointestinal symptoms – a prospective studyFam Pract2005221586115644385
- CarterDLeviGTzurDNovisBAvidanBPrevalence and predictive factors for gastrointestinal pathology in young men evaluated for iron deficiency anemiaDig Dis Sci20135851299130523192647
- LiuKKaffesAJIron deficiency anaemia: a review of diagnosis, investigation and managementEur J Gastroenterol Hepatol201224210911622157204
- McCannJCAmesBNAn overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral functionAm J Clin Nutr200785493194517413089
- BangSMLeeJOKimYJAnemia and activities of daily living in the Korean urban elderly population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA)Ann Hematol2013921596522956182
- AndoKMoritaSHigashiTHealth-related quality of life among Japanese women with iron-deficiency anemiaQual Life Res200615101559156316826432
- BartonJCBartonEHBertoliLFGothardCHSherrerJSIntravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementationAm J Med20001091273210936475
- KulniggSGascheCSystematic review: managing anaemia in Crohn’s diseaseAliment Pharmacol Ther20062411–121507152317206940
- SchroderOMickischOSeidlerUIntravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease–a randomized, controlled, open-label, multicenter studyAm J Gastroenterol2005100112503250916279906
- Van AsscheGDignassABokemeyerBEuropean Crohn’s and Colitis OrganisationSecond European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situationsJ Crohns Colitis20137113323040453
- AMAG Pharmaceuticals IncFeraheme (ferumoxytol) Injection [Prescribing Information]Waltham, MAAMAG Pharmaceuticals, Inc2015
- JahnMRAndreasenHBFuttererSA comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implicationsEur J Pharm Biopharm201178348049121439379
- Vadhan-RajSStraussWFordDEfficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral ironAm J Hematol201489171223983177
- YellenSBCellaDFWebsterKBlendowskiCKaplanEMeasuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJ Pain Symptom Manage199713263749095563
- WareJEJrSherbourneCDThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionMed Care19923064734831593914
- PatrickDLGagnonDDZagariMJMathijsRSweetenhamJEpoetin Alfa Study GroupAssessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfaEur J Cancer200339333534512565986
- CellaDEtonDTLaiJSPetermanAHMerkelDECombining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scalesJ Pain Symptom Manage200224654756112551804
- CellaDLaiJSChangCHPetermanASlavinMFatigue in cancer patients compared with fatigue in the general United States populationCancer200294252853811900238
- NormanGRSloanJAWyrwichKWInterpretation of changes in health-related quality of life: the remarkable universality of half a standard deviationMed Care200341558259212719681
- HetzelDStraussWBernardKLiZUrbonieneAAllenLFA phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapyAm J Hematol201489664665024639149
- KoutroubakisIEOustamanolakisPKarakoidasCMantzarisGJKouroumalisEASafety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel diseaseDig Dis Sci20105582327233119834803
- KhalilAGoodhandJRWahedMYeungJAliFRRamptonDSEfficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practiceEur J Gastroenterol Hepatol201123111029103521857526
- KulniggSStoinovSSimanenkovVA novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trialAm J Gastroenterol200810351182119218371137
- LindgrenSWikmanOBefritsRIntravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre studyScand J Gastroenterol200944783884519330567
- HetzelDStraussWBernardKLiJAllenLIV iron treatment of iron deficiency anaemia with ferumoxytol in patients with gastrointestinal disorders unable to take oral iron: a randomized controlled trial versus iron sucrose [Abstract P485]J Crohns Colitis20137S204
- StraussWDahlNVVadhan-RajSEffects of IV iron treatment with ferumoxytol on health related quality of life of patients with iron deficiency anemiaJ Commun Support OncolIn Press2016
- GlaspyJBukowskiRSteinbergDTaylorCTchekmedyianSVadhan-RajSImpact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study GroupJ Clin Oncol1997153121812349060566